First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

IntroductionBrain metastases commonly occur in patients with non-small cell lung cancer (NSCLC). Standard first-line treatment for NSCLC, without an EGFR, ALK or ROS1 mutation, is either chemoimmunotherapy or anti-PD-1 monotherapy. Traditionally, patients with symptomatic or untreated brain metastas...

Full description

Bibliographic Details
Main Authors: Lauren Julia Brown, Victor Khou, Chris Brown, Marliese Alexander, Dasantha Jayamanne, Joe Wei, Lauren Gray, Wei Yen Chan, Samuel Smith, Susan Harden, Antony Mersiades, Lydia Warburton, Malinda Itchins, Jenny H. Lee, Nick Pavlakis, Stephen J. Clarke, Michael Boyer, Adnan Nagrial, Eric Hau, Ines Pires da Silva, Steven Kao, Benjamin Y. Kong
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
brain metastases
immune checkpoint inhibitor
chemoimmunotherapy
stereotactic radiosurgery
whole brain radiotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1305720/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1305720/full

Similar Items